Richard B Kennedy Selected Research

Rubella (German Measles)

1/2021	Transcriptional signatures associated with rubella virus-specific humoral immunity after a third dose of MMR vaccine in women of childbearing age.
12/2020	Durability of humoral immune responses to rubella following MMR vaccination.
11/2020	Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine.
1/2020	Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.
1/2019	Seroprevalence and durability of rubella virus antibodies in a highly immunized population.
1/2018	Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.
1/2017	Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology.
3/2015	Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination.
11/2014	Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination.
8/2014	Genome-wide SNP associations with rubella-specific cytokine responses in measles-mumps-rubella vaccine recipients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard B Kennedy Research Topics

Disease

19	Measles 12/2020 - 01/2007
18	Rubella (German Measles) 01/2021 - 01/2007
17	Smallpox (Variola) 01/2022 - 05/2009
15	Human Influenza (Influenza) 12/2021 - 07/2012
11	Infections 12/2022 - 02/2010
9	Mumps 01/2022 - 01/2007
6	Vaccinia 01/2022 - 05/2009
4	Communicable Diseases (Infectious Diseases) 01/2020 - 05/2014
3	COVID-19 12/2022 - 10/2020
3	Zika Virus Infection 01/2021 - 01/2018
3	Virus Diseases (Viral Diseases) 01/2020 - 09/2011
2	Lymphocytosis 01/2022 - 12/2021
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 12/2021
2	Poxviridae Infections 01/2020 - 01/2016
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022
1	Microcephaly 01/2021
1	Bites and Stings (Sting) 01/2020
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2019
1	Congenital Abnormalities (Deformity) 01/2018
1	Wilms Tumor (Wilm's Tumor) 01/2018
1	Febrile Seizures (Febrile Seizure) 01/2017
1	Cicatrix (Scar) 01/2016
1	Vaccine-Preventable Diseases 01/2016
1	Hepatitis C 05/2014
1	Malaria 05/2014
1	Tuberculosis (Tuberculoses) 05/2014
1	Inflammation (Inflammations) 01/2013
1	Mpox (monkeypox) 12/2010

Drug/Important Bio-Agent (IBA)

52	VaccinesIBA 01/2022 - 06/2009
19	Neutralizing AntibodiesIBA 12/2022 - 05/2009
15	CytokinesIBA 01/2022 - 01/2007
9	Immunoglobulin G (IgG)IBA 10/2021 - 02/2010
8	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2022 - 08/2014
8	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2021 - 07/2012
8	Measles VaccineIBA 01/2019 - 02/2012
7	Messenger RNA (mRNA)IBA 12/2022 - 11/2012
7	AntibodiesIBA 10/2021 - 01/2007
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2015
5	Interleukin-6 (Interleukin 6)IBA 01/2018 - 04/2010
5	Cytokine Receptors (Cytokine Receptor)IBA 11/2014 - 01/2007
4	AntigensIBA 12/2022 - 01/2018
4	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 01/2022 - 10/2013
4	Interleukin-10 (Interleukin 10)IBA 11/2020 - 01/2007
4	Interleukin-2 (IL2)IBA 10/2013 - 01/2007
3	ProteomeIBA 01/2022 - 03/2015
3	EnzymesIBA 01/2020 - 02/2012
3	ImmunosorbentsIBA 01/2020 - 02/2012
3	Antiviral Agents (Antivirals)IBA 01/2018 - 11/2014
2	ChemokinesIBA 01/2022 - 01/2016
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022 - 12/2010
2	Mumps Vaccine (Vaccine, Mumps)IBA 01/2022 - 01/2019
2	Immunoglobulin A (IgA)IBA 10/2021 - 01/2016
2	EpitopesIBA 10/2021 - 02/2010
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2016
2	InterferonsIBA 01/2018 - 01/2007
2	Protein Isoforms (Isoforms)IBA 01/2017 - 07/2012
2	HLA-DPB1 antigen (HLA DPB1)IBA 03/2015 - 02/2010
2	Interleukin-18 (Interleukin 18)IBA 11/2013 - 08/2011
1	Herpes Zoster VaccineIBA 01/2022
1	ElementsIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 10/2021
1	InflammasomesIBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 11/2020
1	COVID-19 VaccinesIBA 10/2020
1	LigandsIBA 01/2020
1	Staphylococcal Protein A (Protein A)IBA 01/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Fc Receptors (Fc Receptor)IBA 01/2018
1	16S Ribosomal RNAIBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	NF-kappa B (NF-kB)IBA 01/2016
1	HLA-DR Antigens (HLA-DR)IBA 01/2016
1	CholesterolIBA 01/2016
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2015
1	DryVax vaccineIBA 09/2014
1	Cell Surface ReceptorsIBA 01/2014
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2014
1	HLA-B Antigens (HLA-B)IBA 01/2013
1	HLA-A Antigens (HLA-A)IBA 01/2013
1	Heme Oxygenase-1IBA 07/2012
1	Biological Warfare AgentsIBA 11/2009
1	InterleukinsIBA 01/2007

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2016